Xgluzit M

Xgluzit M combines Dapagliflozin and Metformin to provide dual action for improved glucose control in type 2 diabetes.

Type:

Antidiabetic

Classification:

Antidiabetic

#ANTIDIABETIC #DPP4 #SGLT2 #GLUCOSE

Product Overview

Xgluzit M offers a combination therapy that leverages insulin sensitization and increased urinary glucose excretion to help manage type 2 diabetes.

Composition

  • Sitagliptin
  • Metformin

Formulation

Tablet

Key Benefits

  • Helps lower blood glucose through dual mechanisms
  • Supports weight management and cardiovascular health
  • Convenient once-daily dosing

Indications

  • Type 2 diabetes mellitus
  • When diet and exercise alone are insufficient
  • When combination therapy is needed for glycemic control

Marketed By

Vee Medi Biotech